GO:0140513 | nuclear protein-containing complex | 13.73% (21/153) | 4.58 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 20.26% (31/153) | 2.97 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 20.92% (32/153) | 2.91 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 16.99% (26/153) | 3.26 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 21.57% (33/153) | 2.72 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 12.42% (19/153) | 3.88 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 21.57% (33/153) | 2.59 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 28.1% (43/153) | 2.11 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 21.57% (33/153) | 2.56 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 21.57% (33/153) | 2.53 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 22.88% (35/153) | 2.36 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 15.03% (23/153) | 3.02 | 0.0 | 0.0 |
GO:0005643 | nuclear pore | 3.92% (6/153) | 6.44 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 25.49% (39/153) | 1.61 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 67.32% (103/153) | 0.66 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 29.41% (45/153) | 1.38 | 0.0 | 0.0 |
GO:0008380 | RNA splicing | 5.23% (8/153) | 4.54 | 0.0 | 0.0 |
GO:0017056 | structural constituent of nuclear pore | 3.27% (5/153) | 6.43 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 30.72% (47/153) | 1.28 | 0.0 | 0.0 |
GO:0016071 | mRNA metabolic process | 5.88% (9/153) | 4.01 | 0.0 | 0.0 |
GO:0005488 | binding | 49.02% (75/153) | 0.85 | 0.0 | 0.0 |
GO:0006397 | mRNA processing | 5.23% (8/153) | 4.12 | 0.0 | 1e-06 |
GO:0032259 | methylation | 4.58% (7/153) | 4.39 | 0.0 | 1e-06 |
GO:0008170 | N-methyltransferase activity | 3.27% (5/153) | 5.62 | 0.0 | 1e-06 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 9.15% (14/153) | 2.57 | 0.0 | 3e-06 |
GO:0009451 | RNA modification | 5.23% (8/153) | 3.81 | 0.0 | 3e-06 |
GO:0008033 | tRNA processing | 3.92% (6/153) | 4.6 | 0.0 | 4e-06 |
GO:0043414 | macromolecule methylation | 3.92% (6/153) | 4.52 | 0.0 | 5e-06 |
GO:0097159 | organic cyclic compound binding | 32.03% (49/153) | 1.02 | 0.0 | 8e-06 |
GO:0006399 | tRNA metabolic process | 4.58% (7/153) | 3.88 | 1e-06 | 1e-05 |
GO:0044238 | primary metabolic process | 30.72% (47/153) | 1.04 | 1e-06 | 1e-05 |
GO:0034470 | ncRNA processing | 4.58% (7/153) | 3.83 | 1e-06 | 1.2e-05 |
GO:0034660 | ncRNA metabolic process | 5.23% (8/153) | 3.43 | 1e-06 | 1.5e-05 |
GO:0044237 | cellular metabolic process | 24.84% (38/153) | 1.16 | 1e-06 | 2.1e-05 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 3.27% (5/153) | 4.7 | 1e-06 | 2.2e-05 |
GO:0008276 | protein methyltransferase activity | 2.61% (4/153) | 5.52 | 2e-06 | 2.5e-05 |
GO:0008152 | metabolic process | 32.68% (50/153) | 0.94 | 2e-06 | 2.7e-05 |
GO:0018216 | peptidyl-arginine methylation | 1.96% (3/153) | 6.69 | 3e-06 | 3.6e-05 |
GO:0018195 | peptidyl-arginine modification | 1.96% (3/153) | 6.69 | 3e-06 | 3.6e-05 |
GO:0140098 | catalytic activity, acting on RNA | 6.54% (10/153) | 2.75 | 3e-06 | 3.9e-05 |
GO:0009987 | cellular process | 32.03% (49/153) | 0.93 | 3e-06 | 3.9e-05 |
GO:0016273 | arginine N-methyltransferase activity | 1.96% (3/153) | 6.52 | 4e-06 | 4.8e-05 |
GO:0016274 | protein-arginine N-methyltransferase activity | 1.96% (3/153) | 6.52 | 4e-06 | 4.8e-05 |
GO:0071704 | organic substance metabolic process | 30.72% (47/153) | 0.94 | 4e-06 | 5.3e-05 |
GO:0000398 | mRNA splicing, via spliceosome | 3.27% (5/153) | 4.3 | 6e-06 | 7e-05 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.27% (5/153) | 4.16 | 9e-06 | 0.00011 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.27% (5/153) | 4.09 | 1.2e-05 | 0.000137 |
GO:0008150 | biological_process | 45.1% (69/153) | 0.64 | 1.5e-05 | 0.000162 |
GO:0006400 | tRNA modification | 2.61% (4/153) | 4.71 | 1.7e-05 | 0.000183 |
GO:0018193 | peptidyl-amino acid modification | 3.27% (5/153) | 3.97 | 1.8e-05 | 0.000194 |
GO:0006913 | nucleocytoplasmic transport | 2.61% (4/153) | 4.58 | 2.4e-05 | 0.000253 |
GO:0120114 | Sm-like protein family complex | 1.96% (3/153) | 5.69 | 2.5e-05 | 0.000261 |
GO:0051169 | nuclear transport | 2.61% (4/153) | 4.52 | 2.9e-05 | 0.000289 |
GO:0003684 | damaged DNA binding | 1.96% (3/153) | 5.6 | 3.1e-05 | 0.000304 |
GO:0006289 | nucleotide-excision repair | 1.96% (3/153) | 5.44 | 4.3e-05 | 0.000423 |
GO:0008168 | methyltransferase activity | 4.58% (7/153) | 2.82 | 6.7e-05 | 0.000639 |
GO:1990904 | ribonucleoprotein complex | 3.92% (6/153) | 3.11 | 7.6e-05 | 0.000716 |
GO:0016886 | ligase activity, forming phosphoric ester bonds | 1.31% (2/153) | 7.11 | 7.8e-05 | 0.000721 |
GO:0016741 | transferase activity, transferring one-carbon groups | 4.58% (7/153) | 2.74 | 9.5e-05 | 0.000864 |
GO:0000178 | exosome (RNase complex) | 1.31% (2/153) | 6.79 | 0.00013 | 0.001159 |
GO:0022618 | protein-RNA complex assembly | 1.96% (3/153) | 4.79 | 0.000177 | 0.001553 |
GO:1905354 | exoribonuclease complex | 1.31% (2/153) | 6.52 | 0.000194 | 0.001601 |
GO:0005849 | mRNA cleavage factor complex | 1.31% (2/153) | 6.52 | 0.000194 | 0.001601 |
GO:0006378 | mRNA polyadenylation | 1.31% (2/153) | 6.52 | 0.000194 | 0.001601 |
GO:1902494 | catalytic complex | 4.58% (7/153) | 2.58 | 0.000189 | 0.00163 |
GO:0001510 | RNA methylation | 1.96% (3/153) | 4.69 | 0.000215 | 0.001744 |
GO:0071826 | protein-RNA complex organization | 1.96% (3/153) | 4.56 | 0.000281 | 0.002249 |
GO:0006479 | protein methylation | 1.96% (3/153) | 4.52 | 0.000306 | 0.002376 |
GO:0008213 | protein alkylation | 1.96% (3/153) | 4.52 | 0.000306 | 0.002376 |
GO:0009057 | macromolecule catabolic process | 3.92% (6/153) | 2.7 | 0.000346 | 0.002652 |
GO:0006406 | mRNA export from nucleus | 1.31% (2/153) | 6.11 | 0.000361 | 0.002685 |
GO:0051028 | mRNA transport | 1.31% (2/153) | 6.11 | 0.000361 | 0.002685 |
GO:0016874 | ligase activity | 3.27% (5/153) | 3.03 | 0.000394 | 0.002895 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.61% (4/153) | 3.49 | 0.000461 | 0.003339 |
GO:0030163 | protein catabolic process | 1.96% (3/153) | 4.3 | 0.000484 | 0.003459 |
GO:0005634 | nucleus | 4.58% (7/153) | 2.32 | 0.000549 | 0.003874 |
GO:0090066 | regulation of anatomical structure size | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0032535 | regulation of cellular component size | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0006405 | RNA export from nucleus | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0046036 | CTP metabolic process | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0006241 | CTP biosynthetic process | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 1.31% (2/153) | 5.65 | 0.000703 | 0.004488 |
GO:0031124 | mRNA 3'-end processing | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0030488 | tRNA methylation | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0050657 | nucleic acid transport | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0042393 | histone binding | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0051236 | establishment of RNA localization | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0050658 | RNA transport | 1.31% (2/153) | 5.52 | 0.000842 | 0.00496 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.31% (2/153) | 5.41 | 0.000993 | 0.005722 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.31% (2/153) | 5.41 | 0.000993 | 0.005722 |
GO:0005198 | structural molecule activity | 4.58% (7/153) | 2.16 | 0.001045 | 0.005958 |
GO:0030532 | small nuclear ribonucleoprotein complex | 1.31% (2/153) | 5.3 | 0.001155 | 0.006451 |
GO:0000387 | spliceosomal snRNP assembly | 1.31% (2/153) | 5.3 | 0.001155 | 0.006451 |
GO:0043933 | protein-containing complex organization | 3.27% (5/153) | 2.63 | 0.001342 | 0.007342 |
GO:0034708 | methyltransferase complex | 1.31% (2/153) | 5.2 | 0.00133 | 0.00735 |
GO:0071840 | cellular component organization or biogenesis | 5.88% (9/153) | 1.74 | 0.001607 | 0.008698 |
GO:0006281 | DNA repair | 3.27% (5/153) | 2.57 | 0.001629 | 0.008731 |
GO:0046907 | intracellular transport | 3.27% (5/153) | 2.55 | 0.001755 | 0.009314 |
GO:0051649 | establishment of localization in cell | 3.27% (5/153) | 2.53 | 0.001821 | 0.009569 |
GO:0006974 | DNA damage response | 3.27% (5/153) | 2.52 | 0.001888 | 0.009733 |
GO:0065003 | protein-containing complex assembly | 2.61% (4/153) | 2.95 | 0.001879 | 0.00978 |
GO:0051168 | nuclear export | 1.31% (2/153) | 4.86 | 0.002146 | 0.010953 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.61% (4/153) | 2.83 | 0.002517 | 0.012493 |
GO:0019941 | modification-dependent protein catabolic process | 2.61% (4/153) | 2.83 | 0.002517 | 0.012493 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.61% (4/153) | 2.83 | 0.002517 | 0.012493 |
GO:0043227 | membrane-bounded organelle | 4.58% (7/153) | 1.91 | 0.002821 | 0.013744 |
GO:0043231 | intracellular membrane-bounded organelle | 4.58% (7/153) | 1.91 | 0.002821 | 0.013744 |
GO:0031123 | RNA 3'-end processing | 1.31% (2/153) | 4.65 | 0.002878 | 0.013897 |
GO:0140657 | ATP-dependent activity | 4.58% (7/153) | 1.84 | 0.003658 | 0.014853 |
GO:0051716 | cellular response to stimulus | 3.27% (5/153) | 2.29 | 0.003716 | 0.014864 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0080009 | mRNA methylation | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0000149 | SNARE binding | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0019905 | syntaxin binding | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0019211 | phosphatase activator activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0001055 | RNA polymerase II activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0045739 | positive regulation of DNA repair | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0003972 | RNA ligase (ATP) activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0005682 | U5 snRNP | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0051054 | positive regulation of DNA metabolic process | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0000350 | generation of catalytic spliceosome for second transesterification step | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0016556 | mRNA modification | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0008452 | RNA ligase activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0046537 | 2,3-bisphosphoglycerate-independent phosphoglycerate mutase activity | 0.65% (1/153) | 8.11 | 0.003627 | 0.014953 |
GO:0051603 | proteolysis involved in protein catabolic process | 2.61% (4/153) | 2.68 | 0.003655 | 0.014953 |
GO:0005681 | spliceosomal complex | 1.31% (2/153) | 4.46 | 0.003711 | 0.014955 |
GO:0033554 | cellular response to stress | 3.27% (5/153) | 2.35 | 0.003186 | 0.015249 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.31% (2/153) | 4.41 | 0.004011 | 0.015691 |
GO:0010498 | proteasomal protein catabolic process | 1.31% (2/153) | 4.41 | 0.004011 | 0.015691 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.31% (2/153) | 4.41 | 0.004011 | 0.015691 |
GO:0004386 | helicase activity | 2.61% (4/153) | 2.71 | 0.003361 | 0.015941 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 1.31% (2/153) | 4.52 | 0.003422 | 0.01595 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.31% (2/153) | 4.52 | 0.003422 | 0.01595 |
GO:0008173 | RNA methyltransferase activity | 1.31% (2/153) | 4.25 | 0.004975 | 0.019183 |
GO:0043412 | macromolecule modification | 11.11% (17/153) | 1.0 | 0.004953 | 0.019237 |
GO:0005515 | protein binding | 16.99% (26/153) | 0.76 | 0.005289 | 0.020248 |
GO:0022607 | cellular component assembly | 2.61% (4/153) | 2.51 | 0.005487 | 0.020857 |
GO:0070552 | BRISC complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0043564 | Ku70:Ku80 complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0070531 | BRCA1-A complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0006282 | regulation of DNA repair | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0008479 | tRNA-guanosine(34) queuine transglycosylase activity | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0018206 | peptidyl-methionine modification | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0032299 | ribonuclease H2 complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0034518 | RNA cap binding complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0005846 | nuclear cap binding complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0034715 | pICln-Sm protein complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0008139 | nuclear localization sequence binding | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0000469 | obsolete cleavage involved in rRNA processing | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0008361 | regulation of cell size | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0034709 | methylosome | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0043484 | regulation of RNA splicing | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0031499 | TRAMP complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0000339 | RNA cap binding | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0006884 | cell volume homeostasis | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0005665 | RNA polymerase II, core complex | 0.65% (1/153) | 7.11 | 0.00724 | 0.023377 |
GO:0043229 | intracellular organelle | 5.88% (9/153) | 1.38 | 0.008119 | 0.025903 |
GO:0043226 | organelle | 5.88% (9/153) | 1.38 | 0.008119 | 0.025903 |
GO:0051641 | cellular localization | 3.27% (5/153) | 2.08 | 0.006986 | 0.026371 |
GO:0019843 | rRNA binding | 1.31% (2/153) | 3.86 | 0.008432 | 0.02643 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.31% (2/153) | 3.86 | 0.008432 | 0.02643 |
GO:0015931 | nucleobase-containing compound transport | 1.31% (2/153) | 3.86 | 0.008432 | 0.02643 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 1.31% (2/153) | 3.98 | 0.007188 | 0.026941 |
GO:0006259 | DNA metabolic process | 3.27% (5/153) | 1.98 | 0.009209 | 0.028697 |
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0006474 | N-terminal protein amino acid acetylation | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0000338 | protein deneddylation | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0004596 | peptide alpha-N-acetyltransferase activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0003910 | DNA ligase (ATP) activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0003909 | DNA ligase activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0016721 | oxidoreductase activity, acting on superoxide radicals as acceptor | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0030041 | actin filament polymerization | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0004784 | superoxide dismutase activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0016433 | rRNA (adenine) methyltransferase activity | 0.65% (1/153) | 6.52 | 0.01084 | 0.031408 |
GO:0016043 | cellular component organization | 4.58% (7/153) | 1.53 | 0.011205 | 0.032288 |
GO:1990234 | transferase complex | 1.96% (3/153) | 2.59 | 0.013762 | 0.039237 |
GO:0006310 | DNA recombination | 1.31% (2/153) | 3.49 | 0.013744 | 0.039394 |
GO:0106413 | RNA dihydrouridine synthase activity | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0017150 | tRNA dihydrouridine synthase activity | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0042274 | ribosomal small subunit biogenesis | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0043527 | tRNA methyltransferase complex | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0008180 | COP9 signalosome | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0000930 | gamma-tubulin complex | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0031515 | tRNA (m1A) methyltransferase complex | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0008097 | 5S rRNA binding | 0.65% (1/153) | 6.11 | 0.014428 | 0.039456 |
GO:0003724 | RNA helicase activity | 1.31% (2/153) | 3.43 | 0.014831 | 0.040148 |
GO:0008186 | ATP-dependent activity, acting on RNA | 1.31% (2/153) | 3.43 | 0.014831 | 0.040148 |
GO:0065008 | regulation of biological quality | 1.31% (2/153) | 3.35 | 0.016528 | 0.044296 |
GO:1901575 | organic substance catabolic process | 3.92% (6/153) | 1.57 | 0.0165 | 0.044442 |
GO:0046051 | UTP metabolic process | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0004550 | nucleoside diphosphate kinase activity | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0006438 | valyl-tRNA aminoacylation | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0006165 | obsolete nucleoside diphosphate phosphorylation | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0046039 | GTP metabolic process | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0006183 | GTP biosynthetic process | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0006228 | UTP biosynthetic process | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0051258 | protein polymerization | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0050684 | regulation of mRNA processing | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0004832 | valine-tRNA ligase activity | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:1903311 | regulation of mRNA metabolic process | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0006366 | transcription by RNA polymerase II | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0031365 | N-terminal protein amino acid modification | 0.65% (1/153) | 5.79 | 0.018003 | 0.044673 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.31% (2/153) | 3.27 | 0.018304 | 0.045005 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.31% (2/153) | 3.27 | 0.018304 | 0.045005 |
GO:0003729 | mRNA binding | 1.31% (2/153) | 3.33 | 0.017112 | 0.045631 |
GO:1901565 | organonitrogen compound catabolic process | 1.96% (3/153) | 2.42 | 0.019066 | 0.046665 |
GO:0016866 | intramolecular transferase activity | 1.31% (2/153) | 3.3 | 0.017704 | 0.046745 |
GO:0070646 | protein modification by small protein removal | 1.31% (2/153) | 3.3 | 0.017704 | 0.046745 |
GO:0009056 | catabolic process | 3.92% (6/153) | 1.51 | 0.019397 | 0.047258 |